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Abstract 
Background: The use of compression garments during exercise is recommended for women 
with breast cancer-related lymphoedema, but the evidence behind this clinical 
recommendation is unclear. The aim of this randomised, cross-over trial was to compare the 
acute effects of wearing versus not wearing compression during a single bout of moderate-
load resistance exercise on lymphoedema status and its associated symptoms in women with 
breast cancer-related lymphoedema. Methods: Twenty-five women with clinically diagnosed, 
stable unilateral breast cancer-related lymphoedema completed two resistance exercise 
sessions, one with compression and one without, in a randomised order separated by a 14 day 
wash-out period. The resistance exercise session consisted of six upper-body exercises, with 
each exercise performed for three sets at a moderate-load (10-12 repetition maximum). 
Primary outcome was lymphoedema, assessed using bioimpedance spectroscopy (L-Dex 
score). Secondary outcomes were lymphoedema as assessed by arm circumferences (percent 
inter-limb difference and sum-of-circumferences), and symptom severity for pain, heaviness 
and tightness, measured using visual analogue scales. Measurements were taken pre-, 
immediately post- and 24 hours post-exercise. Results: There was no difference in 
lymphoedema status (i.e., L-Dex scores) pre- and post-exercise sessions or between the 
compression and non-compression condition [Mean (SD) for compression pre-, immediately 
post- and 24 hours post-exercise: 17.7 (21.5), 12.7 (16.2) and 14.1 (16.7), respectively; no 
compression: 15.3 (18.3), 15.3 (17.8), and 13.4 (16.1), respectively]. Circumference values 
and symptom severity were stable across time and treatment condition. Conclusions: An 
acute bout of moderate-load, upper-body resistance exercise performed in the absence of 
compression does not exacerbate lymphoedema in women with breast cancer-related 
lymphoedema. 
Keywords: Breast cancer; compression; exercise; lymphoedema.  
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Introduction 
Arm lymphoedema occurs in 20% of women following breast cancer [1]. 
Lymphoedema is characterised by protein-rich fluid accumulating within the interstitial 
spaces as a consequence of an imbalance between lymph load and transport capacity [2, 3]. 
Clinically, breast cancer-related lymphoedema (BCRL) presents as swelling to the arm and/or 
trunk region on the affected side. It contributes to upper-body morbidity including the 
presence of pain, heaviness, tightness, weakness, and poor range of movement of the arm and 
shoulder, as well as psychosocial concerns including reduced self-esteem, depression and 
anxiety [4-8]. It is a feared breast cancer treatment sequelae, deserving of preventive, early 
diagnosis and management efforts. 
A growing and compelling body of literature has been used to inform breast cancer 
survivorship guidelines, with these guidelines highlighting the importance of participating in 
regular, moderate-load exercise post-breast cancer. Exercise leads to improvements in 
physical and psychosocial wellbeing, overall quality of life, and has been linked with 
prevention of future chronic disease and improvements in disease-specific and overall-
survival post-breast cancer [9-14]. Specifically in relation to lymphoedema, participation in 
regular resistance exercise has been linked with reducing the risk of lymphoedema, in 
particular for those who have ≥5 axillary nodes removed as part of their surgical treatment for 
breast cancer, as well as effective management of the condition and its associated symptoms 
[10, 11, 15, 16]. 
The current clinical recommendation for individuals with lymphoedema is to wear 
compression sleeves while exercising [17], but the evidence behind these clinical 
recommendations is unclear [18]. It may simply be because daily compression of the 
lymphoedematus limb is the most common form of lymphoedema treatment [19] and that it is 
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possible to exercise while wearing compression (that is, individuals can continue with 
prescribed treatment even when exercising), or that the pressure from the compression 
garment against the contracting muscle may promote lymph flow and/or doesn’t allow the 
tissue to extend further. Current guidelines may also be influenced by previous landmark 
studies [16, 20] in which all participants wore compression during exercise, although of note, 
guidelines informed the protocol regarding garment wear in these studies. Alternatively, use 
of compression during exercise has been associated with enhanced blood circulation, reduced 
blood lactate concentrations during exercise and facilitation of lactate removal following 
exercise, reductions in swelling and perceptions of pain, enhanced warm-up, improved 
exercise performance and reduced effects of delayed onset muscle soreness [21-27]. These 
effects may be perceived as desirable for those with an impaired lymphatic system, such as 
those with lymphoedema. However, the necessity to wear compression is a major concern 
described by women with BCRL, resulting in negative effects on body image and function 
[28-30]. Women with BCRL have reported exercise to be ‘harder’ when compression is worn 
while exercising [31]. Compression use can cause discomfort, impede mobility, impair with 
heat transfer mechanisms [23, 26, 30-32], and may present as a barrier to regular participation 
in exercise for women with BCRL [32]. Thus, scientifically evaluating the need for the 
clinical guideline is warranted. 
Two studies, conducted by Johansson et al. [31, 33], provide preliminary evidence 
regarding the need, or lack thereof, for compression during exercise for those with BCRL. 
The first study involved 31 women with unilateral BCRL, undertaking an acute, low-intensity 
resistance exercise session with or without compression [31]. Order of compression/no 
compression sessions was randomised and sessions were performed on different days. 
Transient increases in total arm volume (water displacement), immediately post-exercise 
were observed for the compression session, but not the session undertaken without 
6 
 
compression, and there was a tendency towards reduced lymphoedema 24 hours post-
exercise, irrespective of whether compression was worn. In a subsequent study, which also 
involved the assessment of lymphoedema pre-, post- and 24 hours post- a moderate to high 
intensity (reported as >15 on the Borg Ratings of Perceived Exertion scale [34]) resistance 
exercise session in the absence of compression (there was no compression condition for 
comparison purposes), similar findings to the original study were observed [33]. That is, 
lymphoedema remained stable between pre- and immediately post-exercise, while there was 
suggestion of a decline in arm volume by 24 hours post-exercise. However, assessment of 
lymphoedema in both these studies was through measurement of arm volume, which is 
insensitive to subtle changes in extracellular fluid, which could differ between compression 
and no compression exercise sessions. Therefore, we sought to advance understanding in this 
area by evaluating the acute response in those with BCRL to a moderate-load bout of 
resistance exercise (the load now routinely recommended to women following breast cancer 
[35]), with and without compression, by evaluating exercise effect on lymphoedema status, 
(through measurement of extracellular fluid and arm size), as well as lymphoedema-
associated symptoms. It was hypothesised that performing moderate-load resistance exercise 
in the absence of compression will not exacerbate lymphoedema.  
 
Methods 
Study Design 
The present study used a multicentre, randomised, cross-over design. Participants 
completed two moderate-load resistance exercise sessions: 1) wearing compression (COMP); 
and 2) without compression (noCOMP). Randomisation (computer-generated by a research 
assistant) occurred in a 1:1 ratio, with participants allocated into their first resistance exercise 
session following baseline assessment. To be eligible for study involvement, participants: (i) 
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must have been diagnosed with unilateral breast cancer between 1-15 years ago, (ii) were 
currently cancer-free and/or have completed active breast cancer treatment (excluding 
hormone therapy), (iii) must have received a clinical diagnosis of BCRL, and (iv) have stable 
lymphoedema. Stable lymphoedema was defined as the absence of therapist-delivered 
treatment and no arm infections requiring antibiotics in the previous three months. A clinical 
diagnosis of BCRL was defined as an inter-limb difference of ≥10% in volume or 
circumference, or >5 cm difference in the sum of circumference between the affected and 
non-affected side [16]. Participants were excluded from participating if they were: (i) over 70 
years old; and/or (ii) diagnosed with any musculoskeletal, cardiovascular or neurological 
disorder that may limit their ability to safely exercise. 
Following ethical approval, potentially eligible women were identified using 
databases held by study researchers (n=126) and were sent study information packages 
between August 2011 and February 2012. Of these, 23 were ineligible, 58 declined to 
participate (e.g., for reasons primarily due to travel and time constraints), and 17 could not be 
contacted to discuss the study further. This left a convenience sample of 28 women with 
clinician-diagnosed, unilateral BCRL providing consent to participate in the study (Figure 1). 
Written informed consent for study participation was also obtained from each woman’s 
general practitioner. All participants were advised to maintain their normal lymphoedema 
self-management strategies, activities of daily living including physical activity patterns, and 
dietary behaviours during study participation.  
Data collection and exercise sessions 
All data collection and exercise sessions were conducted by Accredited Exercise 
Physiologists with experience in exercise prescription for women with breast cancer. Neither 
the participants nor the exercise physiologist conducting outcome assessments were blinded 
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to the exercise condition. The testing protocol, including data collection and testing sessions 
is outlined in Figure 1. The participants completed four familiarisation visits, over a period of 
two weeks, prior to the experimental exercise sessions. During these sessions, participants 
were instructed on the correct technique of six resistance exercises, targeting all major upper-
body muscle groups. Intensity of these familiarisation sessions progressed from very light 
(two sets of 15-20 repetitions with minimal weight) during the first session, through to 
moderate load resistance (three sets of 10-12 repetitions) by the final familiarisation session. 
The weight lifted for each set was adjusted so that 10-12 repetitions could be completed per 
set with the final repetition in each set requiring near maximal effort for a successful lift. 
Resistance exercises undertaken during familiarisation and testing sessions included chest 
press, bent-over row, bicep curl, triceps extension, lateral raise and wrist curl. Data collection 
sessions occurred immediately before, after and 24 hours post-exercise (Figure 1). Regular 
compression sleeve use prior to the first experimental exercise session (i.e., outside the study) 
was kept consistent for the second session. Participants were asked to remove their garments 
(when relevant) at the beginning of all data collection sessions, and then reapplied the 
garment on completion of the data collection session (unless they were about to participate in 
the COMP exercise session). For the exercise sessions, three sets of six exercises were 
performed with two minutes rest between each set and between each exercise. Each set was 
performed with a load corresponding to the maximum amount of repetitions that could be 
performed 10-12 times (i.e., 10-12 RM [36]). Familiarisation and testing sessions included an 
appropriate warm-up and cool-down period, which involved 5-10 minutes of low-intensity 
aerobic exercise (walking or stationary cycling) and static stretching of all major upper-body 
muscle groups. The two experimental exercise sessions (COMP and noCOMP) were 
separated by at least a 6 day wash-out period. When available, participants wore their own 
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compression garment during the COMP condition (n=20), or were provided with a 
personally-fitted compression sleeve (n=5; Venosan 7002 [23-32 mmHg]).  
Outcomes of interest 
Arm lymphoedema, was assessed with standard objective methods including 
bioimpedance spectroscopy (BIS, primary outcome) to assess extracellular fluid and 
measurements of arm circumferences [37-40] to assess arm size. BIS is a previously well-
described, reliable, sensitive, objective method to assess pitting and/or subclinical 
lymphoedema [41-44]. It is used to measure the impedance of the extracellular fluid for each 
limb, with the ratio of these values, comparing the affected and non-affected limbs then 
calculated (SFB7, Impedimed, Brisbane, Australia). The ratio of impedance values is then 
converted to an L-Dex score; lymphoedema is present when L-Dex is >10, and lymphoedema 
has worsened (that is, extracellular fluid has increased in the affected limb) when the L-Dex 
score increases by ≥10 (equivalent to a 10% increase in the impedance ratio). 
Secondary outcomes were lymphoedema assessed by arm size using arm 
circumferences, and symptom severity. Arm circumference measurements have shown to be 
a reliable technique for assessing lymphoedema [38]. Circumference measurements were 
performed as per Australasian Lymphology Association protocols [45], with participants 
seated upright with their arm positioned at 90° abduction, rested on a measuring board (Jobst, 
North Carolina, USA). Participants maintained their shoulders straight and level, with legs 
uncrossed. A set-square was used to ensure accurate and reproducible marking of the limb 
[45]. The locations of the tip of the third finger, the mid-point of the ulnar and radial 
metacarpo-phalangeal joints and the ulnar styloid process were recorded and a set-square was 
used to mark 5-cm increments from the ulnar styloid mark up to the participant’s axillary 
fold. Measurements were taken using a constant tension measuring tape. Arm circumference 
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measures were reported as the sum-of-circumferences (centimetres) of the affected arm and 
the percentage difference in the sum-of-circumferences between the affected and non-
affected arms. The severity of lymphoedema-associated symptoms including pain, heaviness 
and tightness were assessed using a visual analogue scale (VAS) of 0 (corresponding to no 
heaviness or tightness) to 10 (severe/worst heaviness or tightness). During the immediate 
post-exercise data collection session, a rating of perceived exertion (RPE) for the session just 
completed was recorded (scale: 6 to 20 [34]), and participants were asked to rate the extent to 
which they agree to the statement ‘I have found this exercise session to be tolerable’ 
(1=strongly disagree; 7=strongly agree).  
Statistical Analyses 
Data were analysed using SPSS Statistics for Windows, Version 21 (IBM SPSS, 
Chicago, IL). Descriptive statistics for baseline characteristics included means and standard 
deviations (SD) for continuous variables, or counts (percentages) for categorical variables. 
Normally distributed continuous outcomes were analysed using repeated measures analyses 
of variance to determine statistically significant condition (COMP and noCOMP) × time 
(pre-exercise, immediately post-exercise, and 24 hours post-exercise) interactions, while 
Bonferroni post-hoc tests were used to identify where these difference lie. All available data 
were used in analyses, with no imputation of data generated. All tests were 2-tailed with a 
criterion α level of 0.05. Sample size calculations indicated that to detect a change in L-dex 
score of 10 units as statistically significant, with power and significance set at 80% and 5% 
(two-tailed), respectively, approximately 22 participants were required. 
 
Results 
Participant characteristics and retention 
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Flow of participants through the study is presented in Figure 1. Three of the 28 
participants who consented to participate and provided baseline information withdrew prior 
to completing any experimental exercise sessions. Reasons included unrelated health 
concerns (n=1), change in work commitments (n=1) and unable to commit time as initially 
intended (n=1). There was no discernible difference in their demographic or lymphoedema-
related characteristics compared with the remaining sample (Table 1). Participants were on 
average aged 61 years and had lymphoedema for a mean of 8 years (Table 1). The majority 
(84%) were overweight or obese. There were no minor or major adverse events during the 
study. Mean (SD) ratings of perceived exertion for both exercise conditions was similar 
(RPE=12.5 (2.1) [COMP] and 12.7 (1.9) [noCOMP]) and corresponded to moderate-
intensity. Participants rated both exercise conditions as being tolerable (COMP: 6.3 (0.9); 
noCOMP: 6.0 (1.5)) with exercise tolerance not influenced by compression. Missing data 
were minimal (BIS measures could not be taken from one participant due to the presence of a 
titanium knee insert; one participant completed the noCOMP condition only and withdrew 
prior to the 24 hour post-exercise data collection session).  
Outcomes of interest 
A statistically significant condition × time interaction was identified for 
lymphoedema assessed using BIS (Table 2), with post-hoc analysis demonstrating that 
following participation in the COMP exercise session, the L-Dex score immediately post-
exercise was lower than the L-Dex score immediately pre-exercise (time p-value <0.01). 
There was no statistically significant or clinically relevant difference over time or between 
testing conditions for all other outcomes of interest, including lymphoedema assessed with 
circumferences (Table 2) and symptom severity (Figure 2). Pre-COMP and noCOMP 
condition, between 38-58% of participants reported either no pain, heaviness or tightness 
(that is, marked 0 on the 0-10 VAS scale) and between 13-29% reported the severity of either 
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their pain, heaviness or tightness as being >1. The mean (SD) for those reporting symptom 
severity as >1 for pain (n=4), heaviness (n=5) or tightness (n=5) pre-COMP was 2.7 (1.4), 3.5 
(1.7), and 3.5 (1.7) respectively, and the mean scores pre-noCOMP for those reporting pain 
(n=3), heaviness (n=9) or tightness (n=8) severity as >1 was 2.4 (2.1), 2.6 (2.2) and 2.8 (2.4) 
respectively. Mean change in sensations over time within the COMP and noCOMP condition 
was minimal [mean change for pain, heaviness and tightness between pre-exercise to 24 hour 
post-COMP condition: -0.1 (0.8), 0.1 (1.2) and -0.1 (0.8), and pre-exercise and 24 hour post-
noCOMP condition: 0.1 (0.4), -0.1 (0.6) and 0.0 (1.1) respectively]. There was also no 
significant change in the proportions of women reporting pain, heaviness and tightness 
severity as >1 after exercise. Nonetheless, as shown in Table 3, there were three individuals 
who reported increases in severity of symptoms by 2 or more units for heaviness (n=1, 
COMP) or tightness (n=2, noCOMP) from pre-exercise to 24 hours post-exercise (range: 2.3 
to 4.6) and five individuals who reported reductions in severity of symptoms by 2 or more 
units for pain (n=1, COMP), heaviness (n=1, COMP) or tightness (n=2/1, COMP/noCOMP) 
from pre-exercise to 24 hours post-exercise (range: 2.1 to 2.5). 
 
Discussion 
The key findings from this study are that arm lymphoedema and lymphoedema-
associated symptoms were not exacerbated in the short-term when moderate-load resistance 
exercise was undertaken without compression, and a single bout of moderate-load resistance 
exercise was well tolerated by all participants, irrespective of whether compression was worn 
during exercise.  
In this study we showed a statistically significant decrease in lymphoedema (as 
assessed by BIS) following moderate-load resistance exercise when compression is worn. 
However, the clinical relevance of the magnitude of this change is questionable and was 
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transient. Interestingly though and in contrast to the findings from our study, Johansson et 
al’s work [31] indicated that lymphoedema increased, albeit of a small magnitude, 
immediately following low-load resistance exercise with compression (as assessed by limb 
volume change). The differences in study findings are likely explained by the different 
exercise protocols (i.e., resistance loads evaluated) and the difference in the method of 
lymphoedema assessment (arm volume measurements versus extracellular fluid measures). 
When assessing lymphoedema status through measurement of volume, it is unclear whether 
any increases observed are a consequence of increases in intracellular fluid (e.g., through 
blood flow increases, which is the normal physiological response to exercise), extracellular 
fluid (which would reflect an increase in lymphoedema), or a combination of the two. 
Measures of lymphoedema using BIS provide a more specific assessment of extracellular 
fluid. When exercising while wearing compression it seems more likely that extracellular 
fluid would decrease than increase when compared with exercise without compression. This 
is because compression has been shown to be an effective form of lymphoedema treatment, 
and the muscle pump represents one of the main ways in which lymph is transported [46]. Of 
clinical relevance though, irrespective of the manner by which lymphoedema status was 
assessed (both in this study and prior work by Johansson et al. [31]), is that the magnitude of 
change observed in lymphoedema immediately following a bout of resistance exercise was 
modest and transient.  
Findings from this study are in line with previous studies which query the necessity of 
compression use during resistance exercise, and reported no exacerbation of lymphoedema 
when performing resistance exercise without compression [31, 33]. Previous studies have 
demonstrated that low-intensity resistance exercise performed in the absence of compression 
does not exacerbate lymphoedema in the short-term, and the current work extends this to 
include resistance exercise of a moderate-load. Moreover, irrespective of whether 
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compression was worn, a single bout of moderate-load resistance exercise was well tolerated 
by all participants. Previous work suggests that compression may act as a form of perceived 
support during exercise [31]. However, our study failed to show that resistance exercise was 
more tolerable when wearing compression. 
Johansson et al’s work reported reductions in pain and heaviness up to 24 hours post-
exercise without compression [31, 33]. Findings from our work cannot be used to either 
confirm or refute these findings. Most of the women in our convenience sample reported 
either no, or low levels of symptom severity (i.e., pain, heaviness or tightness) prior to 
exercise, which limited our ability to see improvements in these self-reported outcomes. 
Conversely though, symptom characteristics of the sample would have improved the ability 
to observe an adverse effect. There was a slight trend suggesting more participants reported 
an increase in pain, heaviness or tightness immediately after or 24 hours after the noCOMP 
condition compared with the COMP condition. However, given the proportion of participants 
reporting an increase and the magnitude of the change, caution needs to be applied before 
drawing strong conclusions about the clinical relevance of these data.  
Compression use during exercise and recovery in non-clinical settings has been 
implicated in facilitating the clearance of muscle metabolites and reducing post-exercise 
swelling and delayed onset muscle soreness [21, 23, 26]. In such cases, compression is 
suggested to influence physiological mechanisms by augmenting local blood flow, reducing 
the magnitude of inflammation-associated swelling and assisting in the clearance of 
myocellular proteins and inflammatory mediators [21, 23, 26]. This may be considered 
desirable, particularly for women with BCRL, given the presence of lymphoedema is an 
indicator of an impaired lymphatic system. While no acute benefits of compression use 
during a resistance exercise session with respect to declines in lymphoedema were observed 
in the current study, future research that measures inflammatory biomarkers may help 
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substantiate or refute this potential physiological rationale for compression use during 
exercise. 
There are possible adverse consequences for suggesting that compression use is 
necessary for safe participation in exercise for these women. Women experience declines in 
physical activity levels following diagnosis of BCRL [32], and as such, clinical practice 
guidelines need to assist women to stay or become appropriately active following BCRL. 
Unfortunately, the need to wear compression during exercise has been identified as a barrier 
to regular exercise participation [32]. Issues associated with wearing compression garments 
during exercise include discomfort and irritation, mobility restrictions, interference with heat 
transfer mechanisms, difficulties in applying and/or removing a garment before and after 
exercise, as well as negative effects relating to body image and self-esteem [29, 32, 47-51]. 
For some, there are also access and affordability issues in acquiring specialist-prescribed and 
fitted garments.  
Limitations of this present study including lack of participant and assessor blinding, 
as well as recruitment of a sample which experienced few and mild lymphoedema-associated 
symptoms. Nonetheless, the objective assessment of outcomes, using standardised procedures 
reduced the risk of measurement bias, and while sample characteristics reduced the ability to 
detect improvements in symptoms, the ability to detect adverse changes in symptoms was 
improved. In summary, findings from this randomised, cross-over designed study suggest that 
failure to wear compression during an acute bout of moderate-load resistance exercise does 
not exacerbate lymphoedema or its associated symptoms. Future research is now required to 
quantify the longer-term effects of exercise in the absence of compression. Until such time as 
these results become available, the recommendation to wear or not wear compression during 
exercise should be considered on an individual basis, taking into consideration patient 
preferences and adherence issues regarding compression use.  
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Figure 1: Participant flow 
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Table 1: Personal, diagnostic and physical activity characteristics of the sample (n = 25) 
 
  
Characteristics  Mean (SD) or n (%) 
Age (years) 61.5 (9.2) 
Weight (kg) 79.9 (15.6) 
Body mass index (kg/m²) 
Underweight (<18.5) 
Normal (18.5–24.9) 
Overweight (25–29.9) 
Obese (≥30) 
30.9 (5.7) 
0 (0%) 
4 (16%) 
10 (40%) 
11 (44%) 
Presence of comorbidities
1
 
0  
1 
2 
3+ 
 
10 (35%) 
6 (21%) 
8 (29%) 
4 (15%) 
Time since cancer diagnosis (years) 9.3 (9.0) 
Cancer stage 
I 
II 
III 
IV 
Missing 
 
5 (20%) 
5 (20%) 
5 (20%) 
2 (4%) 
9 (36%) 
Adjuvant treatment (yes) 
Radiotherapy  
Chemotherapy 
Hormone therapy (currently and/or previously) 
 
21 (84%) 
19 (76%) 
14 (56%) 
Surgery (Yes) 24 (96%) 
Full axillary clearance (yes) 19 (76%) 
Number of lymph nodes dissected 16 (8.1) 
Years since lymphoedema diagnosis 7.8 (8.4) 
Lymphoedema treatment in previous 3 months (yes) 8 (32%) 
Currently physically active
2
 (yes) 19 (76%) 
1 
Comorbidities include hypertension/ high blood pressure, high cholesterol, 
cardiovascular disease or heart disease, diabetes, and osteoporosis 
2 
Physically active defined as meeting the Australian national physical activity 
guidelines [52] 
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Table 2: Lymphoedema status, as measured by bioimpedance spectroscopy and 
circumference measurements, for compression and no compression conditions pre-exercise, 
immediately post-exercise and 24 hours post-exercise 
 Compression 
Mean (SD) 
No Compression 
Mean (SD) 
p-value
2
 
BIS (L-Dex score)
1 
(n = 23)  <0.01 
Pre-exercise 
Immediately post-exercise 
24 hours post-exercise 
17.7 (21.5) 
12.7 (16.2)* 
14.1 (16.7) 
15.3 (18.3) 
15.3 (17.8) 
13.4 (16.1) 
 
 
 
Percentage difference between affected  
and unaffected limb (%)
3 
(n = 24) 
 0.89 
Pre-exercise 
Immediately post-exercise 
24 hours post-exercise 
6.8 (6.1) 
6.6 (5.8) 
6.9 (5.7) 
7.9 (7.3) 
7.8 (7.7) 
6.9 (6.0) 
 
 
 
Total circumference on affected  
limb (cm) (n = 24) 
 0.99 
Pre-exercise 
Immediately post-exercise 
24 hours post-exercise 
279.1 (51.5) 
280.3 (51.7) 
278.9 (51.1) 
281.0 (50.8) 
282.3 (51.4) 
278.8 (51.2) 
 
 
 
1 
BIS L-Dex score ≥ 10 indicates Lymphoedema. An increase in L-Dex represents a 
worsening of lymphoedema 
2 
p-values represent an overall time (Pre-exercise, immediately post-exercise and 24 hours 
post exercise) × condition (Compression and no compression) value 
3 
Represents the percentage difference of the sum of circumferences of affected and 
unaffected limb 
*Statistically significant difference between pre-exercise and immediately post-exercise (p = 
0.03) 
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Table 3: Number of participants reporting a change in symptom severity of ≥2 units in VAS 
scores for pain, heaviness and tightness from pre-exercise to immediately post exercise, and 
from pre-exercise to 24 hours post-exercise. 
 
 
 COMP noCOMP 
Pain 
   ∆ Post-exercise 
   ∆ 24 hours post exercise 
 
↑ (n=0); ↓ (n=1) 
↑ (n=0); ↓ (n=1) 
 
↑ (n=1); ↓ (n=0) 
↑ (n=0); ↓ (n=0) 
Heaviness 
   ∆ Post-exercise 
   ∆ 24 hours post exercise 
 
↑ (n=0); ↓ (n=0) 
↑ (n=1); ↓ (n=1) 
 
↑ (n=2); ↓ (n=1) 
↑ (n=0); ↓ (n=0) 
Tightness 
   ∆ Post-exercise 
   ∆ 24 hours post exercise 
 
↑ (n=0); ↓ (n=0) 
↑ (n=0); ↓ (n=2) 
 
↑ (n=1); ↓ (n=1) 
↑ (n=2); ↓ (n=1) 
∆ Post-exercise indicates change from pre-exercise to immediately post exercise 
∆ 24 hours post exercise indicates change from pre-exercise to 24 hours post exercise 
↑ Number of participants reporting an ≥2 unit increase in VAS score 
↓ Number of participants reporting an ≥2 unit reduction in VAS score 
